ePrivacy and GPDR Cookie Consent by Cookie Consent

Studies & Degrees in Drug Research and Development

Choose where you would like to study Drug Research and Development:

DenmarkIndiaNetherlandsRussiaSpainThe United KingdomThe United StatesUkraine

The Americans are lucky enough to have access to the safest and highly-advanced pharmaceutical system than anywhere else in the world.

The pharmaceutical system is closely monitored by the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research or CDER. Their primary responsibility is to evaluate new drugs before they can be released and sold to the public. This does not only prevent the spread of fake and harmful drugs, they also provide the health care professionals and their patients with information regarding the proper use of medications. Because of this strategy, both doctors and patients are forewarned about the harmful and advantageous effects of branded and generic medications to their health making sure that it outweighs the former. Before the drugs are being sold to the country, they should be primarily tested by the drug company who has developed them after which they are to send the results of the test to the CDER. The company’s data and proposed labeling for the drug are then reviewed by a group of physicians, statisticians, chemists, pharmacologists as well as other scientists. If the result of the review is more inclined to the drug’s health benefits thus outweighing the risks, it can now be sold to the public. Drug research is a very important study because it determines the drug’s quality, safety and effectiveness.

It is the company’s accountability to sponsor laboratory and animal tests in order to know exactly what and how the drug works and whether or not it is safe to use in humans. Once this is done, a series of tests in people is started to identify if the drug is safe when being used as a treatment of a disease and whether or not it offers real health benefits. This is how the directions for use, side effects and adverse effects, and warnings are recognized.

The Food and Drug Administration has joint forces with the National Cancer Institute, the pharmaceutical industry as well as the academia, as part of their Critical Path initiative to facilitate the development of new imaging technologies which will be used during the development of products. It is believed that the imaging agents and technologies will contribute necessary biomarkers and surrogate endpoints during the progression of a disease and provide the development of new therapies to treat them.

Drug Research and Development can anticipate and resolve the scientific and technical obstacles before they can become much more. Through the applicability of research, the challenges and gaps in the drug process can be resolved. Gaps unaddressed by traditional basic research and the resolution to specific scientific challenges can be filled through the research programs. The traditional basic drug research is ultimately linked with applied research so as to acknowledge the concerns that arise in the pre-marketing and post-marketing stages. The Drug Research and Development works collaboratively with other research programs of government agencies, pharmaceutical industries and the academia.

Drug Research and Development is tasked to investigate applied and theoretical concerns in the communication of risk and benefit date in direct-to-consumer and professional promotionally prescribed drug materials. It depends on what research program is being used to utilize a number of various research methodologies which includes surveys and experimental research, and for developmental purposes, qualitative research.